Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Revenue

Ambee Pharmaceuticals had revenue of 28.30M BDT in the quarter ending March 31, 2026, a decrease of -47.84%. This brings the company's revenue in the last twelve months to 157.61M, down -32.99% year-over-year. In the fiscal year ending June 30, 2025, Ambee Pharmaceuticals had annual revenue of 230.55M with 5.13% growth.

• Revenue (ttm): 157.61M
• Revenue Growth: -32.99%
• P/S Ratio: 11.63
• Revenue / Employee: 332.51K
• Employees: 474
• Market Cap: 1.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	230.55M	11.25M	5.13%
Jun 30, 2024	219.30M	21.21M	10.71%
Jun 30, 2023	198.10M	17.10M	9.45%
Jun 30, 2022	180.99M	82.02M	82.86%
Jun 30, 2021	98.98M	-186.33M	-65.31%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error